Meritage Portfolio Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.96M | Sell |
|
|||||
|
2025
Q2 | $1.9M | Buy |
|
|||||
|
2025
Q1 | $1.93M | Buy |
|
|||||
|
2024
Q4 | $1.74M | Buy |
|
|||||
|
2024
Q3 | $1.38M | Buy |
|
|||||
|
2024
Q2 | $1.07M | Buy |
|
|||||
|
2024
Q1 | $1.35M | Sell |
|
|||||
|
2023
Q4 | $1.24M | Buy |
|
|||||
|
2023
Q3 | $994K | Buy |
|
|||||
|
2023
Q2 | $502K | Buy |
|
|||||
|
2023
Q1 | $459K | Buy |
|
|||||
|
2022
Q4 | $449K | Buy |
|
|||||
|
2022
Q3 | $414K | Buy |
|
|||||
|
2022
Q2 | $339K | Sell |
|
|||||
|
2022
Q1 | $388K | Buy |
|
|||||
|
2021
Q4 | $319K | Buy |
|
|||||
|
2021
Q3 | $271K | Buy |
|
|||||
|
2021
Q2 | $293K | Buy |
|
|||||
|
2021
Q1 | $210K | Buy |
|